Agree with you, I saw no reason why the Sophs would put money into a share for as little as .002cents per share although it may represent 10%.
Looking like, we are almost ready for the rerate any time now. I bought more at 2.4 cents, wanted to buy more at or below 2.2c. The reason is we have a steadily growing company on one hand and a dying opposition at the other hand, in an atmosphere of a growing cannabis market. Like others who think similar, I am surprised why many have residual concerns? If you can name a few with better potential I am keen to know while I hope ECS becomes a game changer for all holders. GLTAH
ECS Price at posting:
2.3¢ Sentiment: Buy Disclosure: Held
